| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95b2990636e57dd9a4d2025b9dd4e285 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D10B2401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D10B2509-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D04B21-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-0063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-0077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-08 |
| filingDate |
2021-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3a3b33be6e39f2a346bc4eb9cfa91c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c56c30abdbbf398991e8b4e997fd340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94258034b9b2ed938ae22088e5fa63de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e41c8f8d2443518962cd0a20192d6a16 |
| publicationDate |
2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021178241-A |
| titleOfInvention |
Time-dependent biological tissue scaffolding |
| abstract |
PROBLEM TO BE SOLVED: To suppress a chronic inflammatory reaction, a mesh having a small amount of residual substances at an implantation site. Also, a mesh that eliminates the high pressure transition between the flexible abdominal wall and the relatively inflexible mesh / tissue complex by being initially supportive and eventually more compatible. After enabling early wound stability, it transitions to a highly compatible state with a substantially unchanged macroporous pore structure throughout the life of the graft, which is good without cross-linking. Fabric or mesh structure that promotes tissue uptake and its manufacturing method. [Selection diagram] FIG. 3C |
| priorityDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |